Merck & Co., Inc. Investing Cash Flow
Merck & Co., Inc. (MRK) reported Investing Cash Flow of -$15.81 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- Merck & Co., Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$5.60B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$10.21B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.20B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$283.00M.
- Merck & Co., Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$13.74B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$7.73B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$14.08B.
- Merck & Co., Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$4.96B.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$15.81B 10-Q · filed 2026-08-07 | -$27.01B derived: sum of 3 quarters · filed 2026-08-07 | -$27.30B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$10.21B 10-Q · filed 2026-05-04 | -$21.41B derived: sum of 2 quarters · filed 2026-05-04 | -$21.69B derived: sum of 3 quarters · filed 2026-05-04 | -$22.46B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$11.20B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$11.48B derived: sum of 2 quarters · filed 2026-02-24 | -$12.25B derived: sum of 3 quarters · filed 2026-08-07 | -$13.74B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$283.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.05B derived: sum of 2 quarters · filed 2026-08-07 | -$2.54B 10-Q · filed 2025-11-05 | -$3.98B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$770.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$2.26B 10-Q · filed 2026-08-07 | -$3.70B derived: sum of 3 quarters · filed 2026-08-07 | -$7.55B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$1.49B 10-Q · filed 2026-05-04 | -$2.93B derived: sum of 2 quarters · filed 2026-05-04 | -$6.78B derived: sum of 3 quarters · filed 2026-05-04 | -$7.84B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.29B derived: sum of 2 quarters · filed 2026-02-24 | -$6.36B derived: sum of 3 quarters · filed 2026-02-24 | -$7.73B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$3.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.91B derived: sum of 2 quarters · filed 2025-11-05 | -$6.29B 10-Q · filed 2025-11-05 | -$6.24B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$1.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$2.44B 10-Q · filed 2025-08-05 | -$2.39B derived: sum of 3 quarters · filed 2026-02-24 | -$2.73B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$1.38B 10-Q · filed 2025-05-02 | -$1.32B derived: sum of 2 quarters · filed 2026-02-24 | -$1.66B derived: sum of 3 quarters · filed 2026-02-24 | -$13.10B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$281.00M derived: sum of 2 quarters · filed 2026-02-24 | -$11.72B derived: sum of 3 quarters · filed 2026-02-24 | -$14.08B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$334.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$11.78B derived: sum of 2 quarters · filed 2024-11-06 | -$14.14B 10-Q · filed 2024-11-06 | -$15.88B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$11.44B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$13.80B 10-Q · filed 2024-08-05 | -$15.55B derived: sum of 3 quarters · filed 2025-02-25 | -$16.51B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$2.36B 10-Q · filed 2024-05-03 | -$4.11B derived: sum of 2 quarters · filed 2025-02-25 | -$5.07B derived: sum of 3 quarters · filed 2025-02-25 | -$6.15B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$1.75B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$2.71B derived: sum of 2 quarters · filed 2025-02-25 | -$3.79B derived: sum of 3 quarters · filed 2025-02-25 | -$4.96B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$962.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$2.04B derived: sum of 2 quarters · filed 2023-11-03 | -$3.21B 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | -$1.08B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$2.25B 10-Q · filed 2023-08-07 | ||||||
| 2022-03-31 | -$1.17B 10-Q · filed 2023-05-05 | |||||||
| 2021-03-31 | -$738.00M 10-Q · filed 2021-05-05 | -$5.52B derived: sum of 2 quarters · filed 2021-05-05 | -$7.67B derived: sum of 3 quarters · filed 2021-05-05 | -$8.55B derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2020-12-31 | -$4.78B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$6.93B derived: sum of 2 quarters · filed 2021-02-25 | -$7.82B derived: sum of 3 quarters · filed 2021-02-25 | -$9.44B 10-K · filed 2021-02-25 | ||||
| 2020-09-30 | -$2.15B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.04B derived: sum of 2 quarters · filed 2020-11-05 | -$4.67B 10-Q · filed 2020-11-05 | -$5.43B derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2020-06-30 | -$882.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.51B 10-Q · filed 2020-08-05 | -$3.27B derived: sum of 3 quarters · filed 2021-05-05 | -$3.08B derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2020-03-31 | -$1.63B 10-Q · filed 2021-05-05 | -$2.39B derived: sum of 2 quarters · filed 2021-05-05 | -$2.20B derived: sum of 3 quarters · filed 2021-05-05 | -$4.63B derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | -$763.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$572.00M derived: sum of 2 quarters · filed 2021-02-25 | -$3.00B derived: sum of 3 quarters · filed 2021-02-25 | -$2.63B 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $191.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$2.23B derived: sum of 2 quarters · filed 2020-11-05 | -$1.87B 10-Q · filed 2020-11-05 | $312.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$2.42B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.06B 10-Q · filed 2020-08-05 | $121.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.78B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $368.00M 10-Q · filed 2020-05-06 | $2.55B derived: sum of 2 quarters · filed 2021-02-25 | $4.21B derived: sum of 3 quarters · filed 2021-02-25 | $4.88B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $2.18B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.84B derived: sum of 2 quarters · filed 2021-02-25 | $4.51B derived: sum of 3 quarters · filed 2021-02-25 | $4.31B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $1.66B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.33B derived: sum of 2 quarters · filed 2019-11-05 | $2.14B 10-Q · filed 2019-11-05 | $2.08B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $673.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $476.00M 10-Q · filed 2019-08-06 | $418.00M derived: sum of 3 quarters · filed 2020-02-26 | $1.09B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | -$197.00M 10-Q · filed 2019-05-08 | -$255.00M derived: sum of 2 quarters · filed 2020-02-26 | $416.00M derived: sum of 3 quarters · filed 2020-02-26 | -$711.00M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | -$58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $613.00M derived: sum of 2 quarters · filed 2020-02-26 | -$514.00M derived: sum of 3 quarters · filed 2020-02-26 | $2.68B 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $671.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$456.00M derived: sum of 2 quarters · filed 2018-11-06 | $2.74B 10-Q · filed 2018-11-06 | $174.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | -$1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.07B 10-Q · filed 2018-08-07 | -$497.00M derived: sum of 3 quarters · filed 2019-02-27 | -$1.39B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $3.19B 10-Q · filed 2018-05-08 | $630.00M derived: sum of 2 quarters · filed 2019-02-27 | -$260.00M derived: sum of 3 quarters · filed 2019-02-27 | -$1.76B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$2.56B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$3.45B derived: sum of 2 quarters · filed 2019-02-27 | -$4.95B derived: sum of 3 quarters · filed 2019-02-27 | -$3.21B 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$890.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$2.39B derived: sum of 2 quarters · filed 2017-11-07 | -$647.00M 10-Q · filed 2017-11-07 | -$1.26B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $243.00M 10-Q · filed 2017-08-08 | -$374.00M derived: sum of 3 quarters · filed 2018-02-27 | -$435.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $1.74B 10-Q · filed 2017-05-09 | $1.12B derived: sum of 2 quarters · filed 2018-02-27 | $1.06B derived: sum of 3 quarters · filed 2018-02-27 | $3.59B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$617.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$678.00M derived: sum of 2 quarters · filed 2018-02-27 | $1.85B derived: sum of 3 quarters · filed 2018-02-27 | -$4.76B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.46B derived: sum of 2 quarters · filed 2016-11-07 | -$4.14B 10-Q · filed 2016-11-07 | $3.06B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $2.52B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$4.08B 10-Q · filed 2016-08-08 | $3.12B derived: sum of 3 quarters · filed 2017-02-28 | -$598.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$6.61B 10-Q · filed 2016-05-09 | $599.00M derived: sum of 2 quarters · filed 2017-02-28 | -$3.12B derived: sum of 3 quarters · filed 2017-02-28 | -$3.17B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $7.20B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.48B derived: sum of 2 quarters · filed 2017-02-28 | $3.43B derived: sum of 3 quarters · filed 2017-02-28 | -$374.00M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$3.72B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$3.77B derived: sum of 2 quarters · filed 2015-11-05 | -$7.58B 10-Q · filed 2015-11-05 | -$6.40B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$3.86B 10-Q · filed 2015-08-06 | -$2.68B derived: sum of 3 quarters · filed 2016-02-26 | -$4.72B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$3.81B 10-Q · filed 2015-05-07 | -$2.63B derived: sum of 2 quarters · filed 2016-02-26 | -$4.67B derived: sum of 3 quarters · filed 2016-02-26 | -$5.80B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.18B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$860.00M derived: sum of 2 quarters · filed 2016-02-26 | -$2.00B derived: sum of 3 quarters · filed 2016-02-26 | -$3.15B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$2.04B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$3.17B derived: sum of 2 quarters · filed 2014-11-10 | -$4.33B 10-Q · filed 2014-11-10 | -$8.72B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | -$1.14B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.29B 10-Q · filed 2014-08-07 | -$6.69B derived: sum of 3 quarters · filed 2015-02-27 | -$8.53B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | -$1.15B 10-Q · filed 2014-05-08 | -$5.55B derived: sum of 2 quarters · filed 2015-02-27 | -$7.39B derived: sum of 3 quarters · filed 2015-02-27 | -$7.69B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | -$4.40B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$6.24B derived: sum of 2 quarters · filed 2015-02-27 | -$6.54B derived: sum of 3 quarters · filed 2015-02-27 | -$6.80B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | -$1.84B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$2.14B derived: sum of 2 quarters · filed 2013-11-07 | -$2.41B 10-Q · filed 2013-11-07 | -$4.09B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | -$298.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$568.00M 10-Q · filed 2013-08-07 | -$2.25B derived: sum of 3 quarters · filed 2014-02-27 | -$2.52B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | -$270.00M 10-Q · filed 2013-05-09 | -$1.95B derived: sum of 2 quarters · filed 2014-02-27 | -$2.22B derived: sum of 3 quarters · filed 2014-02-27 | -$3.27B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | -$1.68B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$1.95B derived: sum of 2 quarters · filed 2014-02-27 | -$3.00B derived: sum of 3 quarters · filed 2014-02-27 | -$2.89B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | -$263.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.31B derived: sum of 2 quarters · filed 2012-11-09 | -$1.21B 10-Q · filed 2012-11-09 | -$2.21B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$1.05B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$943.00M 10-Q · filed 2012-08-07 | -$1.95B derived: sum of 3 quarters · filed 2013-02-28 | -$1.76B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $105.00M 10-Q · filed 2012-05-08 | -$902.00M derived: sum of 2 quarters · filed 2013-02-28 | -$708.00M derived: sum of 3 quarters · filed 2013-02-28 | -$244.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$813.00M derived: sum of 2 quarters · filed 2013-02-28 | -$349.00M derived: sum of 3 quarters · filed 2013-02-28 | -$3.50B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $194.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $658.00M derived: sum of 2 quarters · filed 2011-11-08 | -$2.49B 10-Q · filed 2011-11-08 | -$2.49B 10-Q · filed 2010-11-08 | -$15.35B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-06-30 | $464.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$2.68B 10-Q · filed 2011-08-08 | -$2.68B 10-Q · filed 2010-08-06 | -$15.55B derived: sum of 3 quarters · filed 2012-02-28 | -$3.54B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-03-31 | -$3.15B 10-Q · filed 2011-05-09 | -$3.15B 10-Q · filed 2010-05-07 | -$16.01B derived: sum of 2 quarters · filed 2012-02-28 | -$4.00B derived: sum of 3 quarters · filed 2012-02-28 | -$1.38B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | -$12.86B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$852.90M derived: sum of 2 quarters · filed 2012-02-28 | $1.77B derived: sum of 3 quarters · filed 2012-02-28 | $3.16B 10-K · filed 2012-02-28 | ||||
| 2009-09-30 | $12.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $14.63B derived: sum of 2 quarters · filed 2010-11-08 | $16.02B 10-Q · filed 2010-11-08 | -$1.31B 10-Q · filed 2009-10-29 | $14.43B derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-06-30 | $2.62B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $4.01B 10-Q · filed 2010-08-06 | -$1.72B 10-Q · filed 2009-07-24 | $2.42B derived: sum of 3 quarters · filed 2011-02-28 | $2.50B derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-03-31 | $1.39B 10-Q · filed 2010-05-07 | -$199.90M derived: sum of 2 quarters · filed 2011-02-28 | -$114.90M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | -$1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$1.50B derived: sum of 2 quarters · filed 2011-02-28 | -$1.83B 10-K · filed 2011-02-28 | -$1.83B 10-K · filed 2010-03-01 | ||||
| 2008-09-30 | $85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$244.00M 10-Q · filed 2009-10-29 | ||||||
| 2008-06-30 | -$329.00M 10-Q · filed 2009-07-24 | |||||||
| 2007-12-31 | -$2.81B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |